logo

For the Inventor, By the Inventor

Montreal, Canada

Paladin Labs Inc.


USPTO Granted Patents = 17



Trademarks = 3

Forward Citations = 173

Loading Chart...
Loading Chart...

36 inventors (with patents filed for the assignee):

goldMedal Damon Smith (11 out of 21 patents)

silverMedal Sonia Gervais (10 out of 18 patents)

bronzeMedal Vinayak Sant (9 out of 12 patents)

4.  Miloud Rahmouni (9 out of 12 patents)

5.  Ali Bichara (9 out of 9 patents)

6.  Frederic Duffayet (8 out of 8 patents)

7.  Shams Rustom (8 out of 8 patents)

8.  Ali El-Jammal (8 out of 8 patents)

9.  Jean-Michel Ndong (8 out of 8 patents)

10.  Angela Ferrada (4 out of 6 patents)

11.  Fouzia Soulhi (4 out of 6 patents)

12.  Bobby-Ernst Boursiquot (4 out of 4 patents)

13.  Rajan George (3 out of 5 patents)

14.  Lorne Tyrrell (3 out of 4 patents)

15.  Antoine A Noujaim (3 out of 18 patents)


17 patents:

1. 10561735 - Solid formulations of liquid biologically active agents (2020-02-18),
2. 9719091 - Oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides and uses thereof (2017-08-01),
3. 9090649 - Oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides and uses thereof (2015-07-28),
4. 8927014 - Misuse preventative, controlled release formulation (2015-01-06),
5. 8927013 - Misuse preventative, controlled release formulation (2015-01-06),
6. 8920834 - Misuse preventative, controlled release formulation (2014-12-30),
7. 8920833 - Misuse preventative, controlled release formulation (2014-12-30),
8. 8895066 - Bilayer composition for the sustained release of acetaminophen and tramadol (2014-11-25),
9. 8691270 - Misuse preventative, controlled release formulation (2014-04-08),
10. 8685447 - Misuse preventative, controlled release formulation (2014-04-01),
11. 8487002 - Controlled-release compositions (2013-07-16),
12. 8486449 - Misuse preventative, controlled release formulation (2013-07-16),
13. 8486448 - Misuse preventative, controlled release formulation (2013-07-16),
14. 8460640 - Narcotic drug formulations with decreased abuse potential (2013-06-11),
15. 8029803 - Chimeric antigens for eliciting an immune response (2011-10-04),
Company Overview
Paladin Labs Inc. is a Canadian pharmaceutical company based in Montreal, specializing in the development and commercialization of innovative healthcare solutions. The organization focuses on enhancing patient care through a diverse portfolio of prescription medications and specialty products. With a commitment to research and development, Paladin Labs collaborates with various partners to bring new therapies to market, addressing unmet medical needs across multiple therapeutic areas. Its strategic approach emphasizes both local and international markets.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Paladin Labs Inc. USPTO Patent Assignee Logo
17 Patents

#58 in Montreal

#884 in Canada

#35,948 in the World

Montreal, CA
Montreal, Canada

Paladin Labs Inc.

Forward Citations = 173

36 inventors:

goldMedal Damon Smith (11 out of 21 patents)

silverMedal Sonia Gervais (10 out of 18 patents)

bronzeMedal Vinayak Sant (9 out of 12 patents)

4.  Miloud Rahmouni (9 out of 12 patents)

5.  Ali Bichara (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Paladin Labs Inc.. Retrieved from https://idiyas.com/company/paladin-labs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…